Thrombosis Prevention and Anticoagulation Management in the Pediatric Patient with Congenital Heart Disease.

Abdelghani, Eman; Cua, Clifford L; Giver, Jean; Rodriguez, Vilmarie

Abdelghani, Eman; Cua, Clifford L; Giver, Jean; Rodriguez, Vilmarie.

Afiliação

Abdelghani E; Division of Pediatric Hematology/Oncology, Nationwide Children's Hospital, Columbus, OH, USA.
Cua CL; Department of Pediatrics, The Ohio State University, Columbus, OH, USA.
Giver J; Heart Center, Nationwide Children's Hospital, 700 Children's Drive, Columbus, OH, USA. Clifford.Cua@nationwidechildrens.org.
Rodriguez V; Department of Pediatrics, The Ohio State University, Columbus, OH, USA. Clifford.Cua@nationwidechildrens.org.

Cardiol Ther ; 10(2): 325-348, 2021 Dec.

Article em En | MEDLINE | ID: mdl-34184214

Palavras-chave

Anticoagulation; Aspirin; Congenital heart disease; Heparin; Thrombosis; Warfarin

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Cardiol Ther Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google